# Ivy, David Dunbar M.D. – FDA Inspection, Feb 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/ivy-david-dunbar-md/e263b8c5-e0b5-49f1-a520-0101fb6f8738
Source feed: FDA_Inspections

> FDA inspection 1006029 of Ivy, David Dunbar M.D., February 23, 2017. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006029
- Company Name: Ivy, David Dunbar M.D.
- Inspection Date: 2017-02-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/ivy-david-dunbar-md/1ac16e97-2350-4fa4-8b3a-129de9bf6909

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c